<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00678067</url>
  </required_header>
  <id_info>
    <org_study_id>DHA-RICH1</org_study_id>
    <nct_id>NCT00678067</nct_id>
  </id_info>
  <brief_title>Effects of Docosahexaenoic and Eicosapentaenoic Acids in Hypercholesterolemic Children Plus Diet on Docosahexaenoic Acid (DHA) Status</brief_title>
  <acronym>DHA-RICHOIL</acronym>
  <official_title>Effects of Docosahexaenoic Acid (DHA) and Eicosapentaenoic Acid(EPA)Supplementation on DHA Plasmatic Status and Blood Lipid Profile in Hypercholesterolemic Children in Addition to National Cholesterol Education Program Step I Diet</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Milan</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Milan</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To examine whether Docosahexaenoic Acid (DHA) and Docosahexaenoic + Eicosapentaenoic Acids
      (DHA+EPA) supplementation in addition to National Cholesterol Education Program Step I Diet
      in Hypercholesterolemic Children increases Docosahexaenoic Acid (DHA) plasma levels in the 2
      intervention groups versus placebo. Secondary outcome measure: effect of DHA and DHA+EPA
      supplementation on blood lipid profile
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In a double-blind placebo-controlled trial 36 hypercholesterolemic children, 3-13 years of
      age, 19 males and 17 females were put on National Cholesterol Education Program (NCEP)Step-I
      diet and randomised into 3 groups to receive 500 mg/day of purified Docosahexaenoic Acid
      (DHA), Docosahexaenoic Acid plus Eicosapentaenoic Acid (DHA+EPA) mixture (228 + 208 mg/day
      respectively), or wheat germ oil as placebo. They underwent at baseline and after a 4 month
      treatment: EPA and DHA levels in total plasma and in phospholipids, triglycerides,
      cholesteryl esters; dietary habits by food frequency questionnaire; blood lipid profile
      (total cholesterol, HDL cholesterol, triglycerides levels)
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>June 2005</start_date>
  <completion_date type="Actual">November 2006</completion_date>
  <primary_completion_date type="Actual">November 2006</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Plasma Docosahexaenoic Acid (DHA) levels in DHA group and DHA+EPA group versus placebo after intervention</measure>
    <time_frame>4 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Blood lipid profile variation in DHA Group and DHA+EPA Group versus placebo group after intervention</measure>
    <time_frame>4 months</time_frame>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">36</enrollment>
  <condition>Hypercholesterolemia</condition>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>12 hypercholesterolemic children 3-13 years of age</description>
  </arm_group>
  <arm_group>
    <arm_group_label>DHA+EPA group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>12 hypercholesterolemic children 3-13 years of age</description>
  </arm_group>
  <arm_group>
    <arm_group_label>DHA Group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>12 hypercholesterolemic children 3-13 years of age</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Docosahexaenoic acid</intervention_name>
    <description>Soft capsules 500 mg/each; 1 capsule/day for 4 months</description>
    <arm_group_label>DHA Group</arm_group_label>
    <other_name>DHA</other_name>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Docosahexaenoic acid (DHA)+ Eicosapentaenoic acid (EPA)</intervention_name>
    <description>Soft capsules, 228 mg DHA + 208 mg EPA /each; 1 capsule/day for 4 months</description>
    <arm_group_label>DHA+EPA group</arm_group_label>
    <other_name>DHA and EPA mixture</other_name>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Germ oil</intervention_name>
    <description>Soft capsules, 275 mg linoleic acid + 35 mg linolenic acid + 65 mg oleic acid /each; 1 capsule/day for 4 months</description>
    <arm_group_label>Placebo</arm_group_label>
    <other_name>wheat germ oil</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>National Cholesterol Education Program (NCEP) Step I Diet</intervention_name>
    <description>Dietary counselling aimed at achieving NCEP Dietary Guidelines: Total fat intake &lt;30% of total calories, Saturated fat intake &lt;10% of total calories, Polyunsaturated fat intake up to 10% of total calories, monounsaturated fat intake 10-15% of total calories</description>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_label>DHA+EPA group</arm_group_label>
    <arm_group_label>DHA Group</arm_group_label>
    <other_name>Dietary intervention</other_name>
    <other_name>Dietary recommendations</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Clinical diagnosis of primary hypercholesterolemia (total cholesterol levels &gt; 200
             mg/dl before entering the study)

          -  BMI &gt;3°and &lt; 97° percentile for age

          -  First referring to our Lipid Clinic

        Exclusion Criteria:

          -  Secondary dyslipidemia

          -  Obesity

          -  Step I diet or any dietary supplement before entering the study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>3 Years</minimum_age>
    <maximum_age>13 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Silvia Decarlis, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Dept. of Pediatrics, San paolo Hospital, University of Milan, Italy</affiliation>
  </overall_official>
  <verification_date>May 2008</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 8, 2008</study_first_submitted>
  <study_first_submitted_qc>May 14, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 15, 2008</study_first_posted>
  <last_update_submitted>May 16, 2008</last_update_submitted>
  <last_update_submitted_qc>May 16, 2008</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 19, 2008</last_update_posted>
  <responsible_party>
    <name_title>Silvia Decarlis, MD</name_title>
    <organization>Dept. of Pediatrics, San Paolo Hospital, University of Milan, Italy</organization>
  </responsible_party>
  <keyword>Hypercholesterolemic children</keyword>
  <keyword>Docosahexaenoic acid</keyword>
  <keyword>Eicosapentaenoic acid</keyword>
  <keyword>Blood lipid profile</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypercholesterolemia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

